Dishman Carbogen Amcis Q1 Results
- BSE: 540701
- NSE: DCAL
- ISIN: INE385W01011
- Sector: Biotechnology & Drugs
BSE
174.55
-8.10 (-4.43%)
-8.10 (-4.43%)Volume10.13 K
Updated: Tue 12 May, 2026 | 15:28:36
NSE
174.71-8.48 (-4.63%)
-8.48 (-4.63%)Volume1.71 L
Updated: Tue 12 May, 2026 | 15:25:43
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Dishman Carbogen Amcis Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 651.37 | 654.49 | -0.48% | 570.84 | 14.11% |
| Depreciation/ Amortization | 81.35 | 79.09 | 2.86% | 70.59 | 15.24% |
| Operating Income | 56.68 | 61.85 | -8.36% | -47.06 | 0.00% |
| Net Income | 23.41 | 43.09 | -45.67% | -77.57 | 0.00% |
| Other Operating Expenses Total | 117.38 | 92.07 | 27.49% | 111.22 | 5.54% |
| Net Income Before Taxes | 38.67 | 27.70 | 39.60% | -77.56 | 0.00% |
| Total Revenue | 708.05 | 716.34 | -1.16% | 523.78 | 35.18% |
| Selling/ General/ Admin Expenses Total | 351.90 | 324.94 | 8.30% | 316.82 | 11.07% |
| Diluted Normalized EPS | 1.59 | 3.24 | -50.89% | -4.71 | 0.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.